Cue Biopharma Director Cameron Gray Resigns from Board

Cue Biopharma, Inc.

Cameron Gray notified Cue Biopharma of his resignation as a Board member on June 16, 2022.
Gray also resigned from all board committees, effective immediately.
The resignation was not related to any disagreement with the company on operations, policies, or practices.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Cameron Gray

Director

CUE · Cue Biopharma, Inc.

Effective: 2022-06-16
Filed: June 22, 2022, 7:59 PM ET

On June 16, 2022, Cameron Gray notified Cue Biopharma, Inc. (the “Company”) of his decision to resign as a member of the Board of Directors of the Company (the “Board”) and all committees thereof, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Cameron Gray resigned as Director at Cue Biopharma, Inc..

Action: resigned
Role: Director

Exact text from the filing

On June 16, 2022, Cameron Gray notified Cue Biopharma, Inc. (the “Company”) of his decision to resign as a member of the Board of Directors of the Company (the “Board”) and all committees thereof, effective immediately.

View on SEC.gov

Cue Biopharma, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-178755

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.